AstraZeneca

​​AstraZeneca full-year earnings: Can the pharma giant maint... IG14:58
Top FTSE 250 and FTSE 100 shares to watch: BP, Barclays, NatWest, AstraZeneca Invezz08:53
Countdown to AstraZeneca (AZN) Q4 earnings: A look at estimates beyond revenue and EPS Zacks15:23
Assessing AstraZeneca (LSE:AZN) valuation after recent steady share performance Simply Wall St20:15
Fatality inquiry hears of link between deadly disorder and AstraZeneca Covid vaccine Calgary Sun00:12
Why AstraZeneca (AZN) dipped more than broader market today Zacks00:16
Week ahead: AstraZeneca, Unilver, BP results due ShareCast17:11

Latest News

Yesterday
AstraZeneca Prize recognises Academic Merit The Portugal News13:16 8-Feb-26
In the last 7 days
Fatality inquiry hears of link between deadly disorder and AstraZeneca Covid vaccine Calgary Sun00:12 7-Feb-26
Week ahead: AstraZeneca, Unilver, BP results due ShareCast17:11 6-Feb-26
BP & AstraZeneca: Stock market week ahead – 9-13 February Investors Chronicle16:18 6-Feb-26
Stocks to watch: BP, Barclays, AstraZeneca, Airbnb, Coinbase Yahoo! UK & Ireland13:28 6-Feb-26
AstraZeneca and Daiichi Sankyo’s Datroway given FDA Priority Review for breast cancer treatment PMLiVE12:32 6-Feb-26
Top FTSE 250 and FTSE 100 shares to watch: BP, Barclays, NatWest, AstraZeneca Invezz08:53 6-Feb-26
Assessing AstraZeneca (LSE:AZN) Valuation After Recent Steady Share Performance Simply Wall St20:15 5-Feb-26
AstraZeneca’s Precision Oncology Approach Applies To Deal, Portfolio Decisions Scrip Pharma Intelligence20:10 5-Feb-26
Countdown to Astrazeneca (AZN) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS Zacks15:23 5-Feb-26
Cambridge A-Listers Arm and AstraZeneca see stock rise in US Business Weekly15:22 5-Feb-26
AstraZeneca to Report Q4 Earnings: What's in Store for the Stock? Zacks14:42 5-Feb-26
Aim ImmunoTech Announces Encouraging Results From Phase 2 Duripanc Study; Stock Up In Pre-market RTT News14:40 5-Feb-26
AstraZeneca opens on NYSE, expands in China Cambridge Independent14:34 5-Feb-26
AstraZeneca’s Imfinzi plus chemotherapy earns Chmp nod in gastric cancer European Pharmaceutical Review12:42 5-Feb-26
AstraZeneca Korea expands Koselugo indication to adult NF1-PN patients Korea Biomedical Review00:18 5-Feb-26
​​AstraZeneca full-year earnings: Can the pharma giant maint... IG14:58 4-Feb-26
AstraZeneca’s Imfinzi regimen receives positive CHMP opinion for early gastric and gastroesophageal cancer PMLiVE13:03 4-Feb-26
AstraZeneca unveils $15bn China investment during Keir Starmer visit FinanceAsia10:44 4-Feb-26
AstraZeneca gets Cdsco approval for Durvalumab in gastric cancer treatment The Hindu Business Line10:06 4-Feb-26
Why Astrazeneca (AZN) Dipped More Than Broader Market Today Zacks00:16 4-Feb-26
Walmart becomes first retailer to hit $1 trillion market valuation The Hindu Business Line17:38 3-Feb-26
NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE… PR Newswire (Press Release)13:59 3-Feb-26
FDA knocks back AstraZeneca's self-injected lupus drug pharmaphorum12:52 3-Feb-26
Datroway® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment … Business Wire (Press Release)12:06 3-Feb-26
AstraZeneca Responds With Data After FDA Delays Lupus Drug Shot Benzinga12:05 3-Feb-26
Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast… AstraZeneca (Press Release)10:48 3-Feb-26
Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus AstraZeneca (Press Release)10:48 3-Feb-26
AstraZeneca & Plus500: Markets live blog Investors Chronicle10:37 3-Feb-26
With 13% annual earnings growth forecast and 45% under ‘fair value’, should I buy more of this… Motley Fool (UK)09:14 3-Feb-26
AstraZeneca says FDA backs Datroway, seeks more assurance on Saphnelo London South East09:12 3-Feb-26
FDA rejects self-injectable version of AstraZeneca lupus drug ShareCast08:11 3-Feb-26
AstraZeneca Seeks to Advance Subcutaneous Saphnelo in US After FDA Complete Response TipRanks07:38 3-Feb-26
Datroway® Granted Priority Review in the U.S. as First-Line Treatment for Patients with… Business Wire (Press Release)07:32 3-Feb-26
AstraZeneca inks billion-dollar deal with China's CSPC Pharma to expand weight management portfolio BioSpectrum Asia06:13 3-Feb-26
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding… PR Newswire (Press Release)22:33 2-Feb-26
US and India reach trade deal, Astrazeneca shares move to NYSE Yahoo! UK & Ireland19:15 2-Feb-26
Pharma is ready to play ball: How brands are excelling with sports partnerships Campaign US18:08 2-Feb-26
AZN Obesity Pipeline to Get a Boost From Deal With China's CSPC Zacks17:01 2-Feb-26
GT Voice: Vitality in China-UK cooperation highlights constructive role of China's outward investment Global Times16:46 2-Feb-26
AstraZeneca wolfs down Wall Street listing Business Weekly15:33 2-Feb-26
NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE in Record… PR Newswire (Press Release)13:59 2-Feb-26
AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration Manufacturing Chemist11:36 2-Feb-26
UK Drugs Giant AstraZeneca Launches Shares On New York Stock Exchange Bernama10:17 2-Feb-26
AstraZeneca hails Imfinzi green light ahead of New York trading debut London South East09:19 2-Feb-26
AstraZeneca lists on New York Stock Exchange Yorkshire Post08:41 2-Feb-26
Imfinzi perioperative raegimen recommended for approval in the EU by CHMP for patients with early gastric and… AstraZeneca (Press Release)08:30 2-Feb-26
AstraZeneca begins trading on the New York Stock Exchange AstraZeneca (Press Release)08:30 2-Feb-26
AstraZeneca shares launch on New York Stock Exchange Evening Standard08:19 2-Feb-26
AstraZeneca Shares to Start Trading in US After Listing Upgrade Bloomberg Law08:16 2-Feb-26
AstraZeneca begins trading directly on the NYSE Proactive Investors (US)08:09 2-Feb-26
London briefing: UK house price growth rises; AstraZeneca joins NYSE London South East07:57 2-Feb-26
Astrazeneca's Imfinzi receives EU recommendation, DiscoverIE Q3 sales rise ShareCast07:34 2-Feb-26
Astrazeneca's Imfinzi receives EU recommendation from Chmp ShareCast07:33 2-Feb-26
In the last month
AstraZeneca signs $18.5 billion weight-loss-drug deal with Chinese firm Chemical & Engineering News22:24 30-Jan-26
AstraZeneca’s China Bet Recasts Growth Story Around Obesity And Diabetes Simply Wall St22:08 30-Jan-26
Interview: With multi-bln dollar investment, AstraZeneca reaffirms confidence in China: CEO Xinhua Agency21:49 30-Jan-26
Astrazeneca doubles down on China with $15B+ investments BioWorld18:56 30-Jan-26
AstraZeneca Beats FMLA Suit After Ex-Worker Went Silent Law36017:49 30-Jan-26
AstraZeneca plans $15 B investment in China to expand medicines manufacturing and R&D BioSpectrum Asia16:18 30-Jan-26
AstraZeneca makes $15bn manufacturing investment in China European Pharmaceutical Review15:05 30-Jan-26
STAT Plus: AstraZeneca looks to China for obesity drug candidates STAT14:45 30-Jan-26
AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC BioPharma Dive14:13 30-Jan-26
AstraZeneca strikes $4.7bn China deal to boost weight-loss drugs pipeline The Irish Times13:28 30-Jan-26
AstraZeneca obesity tie-up with CSPC seen as shrewd move Proactive Investors (UK)13:10 30-Jan-26
AstraZeneca CEO: Investing in Chinese market essential for innovation CGTN13:10 30-Jan-26
Twenty-Two Genes Could Hike Risk for Long-Term Health Issues After Epstein-Barr... Genetic Engineering and Biotechnology News13:09 30-Jan-26
AstraZeneca and CSPC Pharmaceuticals enter collaboration on weight management therapies PMLiVE12:51 30-Jan-26
AstraZeneca doubles down on China with $15 billion investment CGTN12:24 30-Jan-26
AstraZeneca Expands Weight Loss Push With Eight-Program China Collaboration Benzinga12:12 30-Jan-26
AstraZeneca signs obesity drugs deal with Chinese firm Macau Business11:59 30-Jan-26
AstraZeneca signs $18.5bn weight loss drug deal with CSPC Pharmaceutical Technology11:48 30-Jan-26
AstraZeneca Seals China Obesity Drug Deal For Up To $18.5B Law36011:31 30-Jan-26
AstraZeneca & Experian: Markets live blog Investors Chronicle11:22 30-Jan-26
AstraZeneca strikes obesity deal with China's Cspc Pharmaceuticals London South East10:05 30-Jan-26
AZ deepens Chinese ties, signs $18.5bn CSPC obesity deal pharmaphorum10:04 30-Jan-26
Trending tickers: Apple, Microsoft, Sandisk, Caterpillar, AstraZeneca Yahoo! UK & Ireland09:54 30-Jan-26
AstraZeneca enhances its weight management portfolio through collaboration agreement with CSPC Pharmaceuticals AstraZeneca (Press Release)09:48 30-Jan-26
AstraZeneca secures tie-up with Chinese firm Yorkshire Post09:16 30-Jan-26
AstraZeneca to license obesity drugs from China’s Cspc in deal worth up to $18.5 billion The Telegraph, Calcutta09:10 30-Jan-26
AstraZeneca secures tie-up with Chinese firm for weight loss drugs Evening Standard08:26 30-Jan-26
AstraZeneca to invest $15BN in China China Economic Review08:19 30-Jan-26
London briefing: Astra inks obesity drug deal; Airtel profit jumps London South East08:03 30-Jan-26
AstraZeneca strikes $1.2bn obesity drug deal with China's CSPC Proactive Investors (US)07:43 30-Jan-26
AstraZeneca strikes collaborative agreement with Cspc Pharmaceuticals London South East07:42 30-Jan-26
Groundbreaking $18.5 Billion Collaboration! Stone Pharmaceutical Group Teams up with… China Money Network07:10 30-Jan-26
AstraZeneca Bets $18.5bn On CSPC’s Sustained-Release And AI Peptide Platforms In Weight Management Scrip Pharma Intelligence06:18 30-Jan-26
China's Cspc Pharmaceutical inks deal with AstraZeneca for weight loss therapy Yahoo! US01:47 30-Jan-26
AstraZeneca to invest £11bn in China after rowing back on UK expansion Yahoo! UK & Ireland18:59 29-Jan-26
Europe bulletin: UK’s ‘long-term’ China play, war tech problems, AstraZeneca’s $15B bet Invezz18:31 29-Jan-26
Starmer and Xi hail reset, with help from AstraZeneca Taipei Times17:48 29-Jan-26
AstraZeneca abandons British projects to invest £11.8bn in China during Starmer visit EasternEye17:47 29-Jan-26
AstraZeneca Bets Big On China With Massive $15 Billion Investment Benzinga17:00 29-Jan-26
AstraZeneca pours $15bn into Chinese R&D and manufacturing operations Pharmaceutical Technology16:10 29-Jan-26
AstraZeneca strengthens China ties with planned $15B investment BioPharma Dive16:00 29-Jan-26
AstraZeneca plans $15bn investment in China by 2030 to expand R&D Investment Monitor15:05 29-Jan-26
STAT Plus: Pharmalittle: We’re reading about AstraZeneca investing in China, an abandoned… STAT14:30 29-Jan-26
AstraZeneca unveils “landmark” $15bn investment in China Insider Media14:15 29-Jan-26
AstraZeneca Stock (AZN) Flattens Despite $15B Investment in Chinese Drug Development TipRanks14:09 29-Jan-26
AstraZeneca unveils $15bn China investment ShareCast13:45 29-Jan-26
AstraZeneca to invest $15B in China through 2030 Anadolu Agency13:39 29-Jan-26
AstraZeneca Announces £11 Billion Investment in China Months After Snubbing Britain Guido Fawkes' Blog13:31 29-Jan-26
Xi, Starmer break the ice as AstraZeneca plans $15bn China investment Nikkei Asian Review13:24 29-Jan-26
AstraZeneca unveils $15 billion investment in China Business Weekly13:21 29-Jan-26
AstraZeneca pledges $15 billion China investment during Starmer trip The Independent13:17 29-Jan-26
AstraZeneca announces $15b investment in China Gulf News13:07 29-Jan-26
AstraZeneca announces $15bn investment in Chinese manufacturing and R&D by 2030 PMLiVE13:06 29-Jan-26
AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities FiercePharma13:00 29-Jan-26
AstraZeneca Hails ‘Next Chapter’ In China With $15bn Investment Pledge Scrip Pharma Intelligence12:50 29-Jan-26
AstraZeneca unveils US$15 billion China investment plan as Starmer visits Beijing South China Morning Post12:23 29-Jan-26
AstraZeneca announces $15bn investment in China Yahoo! UK & Ireland11:51 29-Jan-26
UK drugs giant AstraZeneca announces $15 bn investment in China Digital Journal11:46 29-Jan-26
Starmer and Xi hail a reset in ties, helped by large AstraZeneca investment Hong Kong Standard11:29 29-Jan-26
AstraZeneca sets out $15 billion China investment during Starmer visit Hong Kong Standard11:29 29-Jan-26
AstraZeneca plots bumper China investment in "exciting next chapter" London South East10:30 29-Jan-26

      
            
      
    view more headlines
   
      
      
      
8 Feb 13:16
   

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

AstraZeneca

Latest News

About our AstraZeneca news

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories